Just in time for the new year Dr. Thomas Langer starts his ageing research at the Max Planck Institute in Cologne
As one of the leading scientists in mitochondrial research Dr. Thomas Langer was selected as the fourth director starting in January 2018; thus filling the last open position as director at the Max Planck Institute for Biology of Ageing. The scientist from southern Germany is already well known in the field of ageing research and has been working in close contact with the Max Planck Institute for Biology of Ageing in Cologne for several years.
“Dr. Thomas Langer is an outstanding scientist”, says managing director Prof. Dr. Adam Antebi about his new colleague. “His research is multidisciplinary ranging from biochemistry of single molecules to organismal physiology, and complements well the work at our institute using model genetic organisms to unravel the ageing process.”
Understanding the highly dynamic and flexible mitochondria is the main focus of the research group of Thomas Langer. Known as the powerhouse of the cell, these cellular components are responsible for the production of energy. However, their function goes far beyond energy production. “Mitochondria are extremely plastic, dynamic and especially variable cell parts that communicate with the rest of the cell in a tissue specific manner”, explains the new director. During the ageing process the activity of mitochondria declines and a dysfunction of these organelles is associated with numerous age-associated diseases. How do mitochondria influence our health and ageing? To answer this question is the goal of the scientists around Thomas Langer.
Since 2000 Dr. Thomas Langer has been working as professor at the Institute for Genetics at the University of Cologne. He became deputy scientific coordinator and principal investigator in 2007 at the CECAD cluster of excellence in aging research, which enabled him to get in close contact with the directors of the cluster-associated Max Planck Institute. Being appointed as new director of the Max Planck Institute for Biology of Ageing allows Dr. Langer to further intensify his research. “The possibilities at the institute are great and I will be able to focus more on research”, adds the new director.
About the person
Dr. Thomas Langer studied biology at the university of Regensburg and subsequently performed his PhD at the Ludwig-Maximilian University in Munich where he graduated in 1993. Following a research visit at the Memorial Sloan-Kettering Cancer Institute in New York, he became research group leader in Munich at the Ludwig-Maximilian University where he also habilitated in 1999. In 2001, he became professor at the University of Cologne at the Institute of Genetics.
Find out more about the research group of Thomas Langer.
You can download the press release here.